ebitda margins
Jump to
154 Results Found
  • Confident of adding 15-16 pumps by end-FY17: Mahanagar Gas Feb 20, 2017 11:29 AM IST

    Confident of adding 15-16 pumps by end-FY17: Mahanagar Gas

    SM Ranade, CFO of Mahanagar Gas is also confident of margins remaining steady going forward.

  • Analysts raise concerns on Havells EBITDA margin post Lloyd deal Feb 20, 2017 10:00 AM IST

    Analysts raise concerns on Havells EBITDA margin post Lloyd deal

    While analysts are comfortably placed with the deal‘s pricing, they have highlighted some challenges such as hit in EBITDA margins, lack of synergies, among others, for Havells that will emerge from this deal.

  • Capacity utilisation to go up in Bihar, W Bengal: Globus Spirits Feb 03, 2017 10:23 AM IST

    Capacity utilisation to go up in Bihar, W Bengal: Globus Spirits

    With the facilities in West Bengal and Bihar getting commissioned there will be increase in capacity utilisation, said Shekhar Swarup, ED, Globus Spirits.

  • See 15-20% growth in plastic biz; Q4 to be better: Sintex Jan 23, 2017 12:00 PM IST

    See 15-20% growth in plastic biz; Q4 to be better: Sintex

    Samir Joshipura, Group CEO, Sintex is very optimistic of the plastic business growing at 15-20 percent post the demerger.

  • See EBITDA margins at 25% over 10 years: Glenmark CMD Dec 19, 2016 06:16 PM IST

    See EBITDA margins at 25% over 10 years: Glenmark CMD

    The company is aiming for at least one outlicensing deal in the next year and Saldanha also feels pharma giant will grow at a 15-20 percent CAGR over the next five years.

  • To maintain EBITDA margins at 32%, topline 10-15%: Suven Life Nov 25, 2016 09:36 AM IST

    To maintain EBITDA margins at 32%, topline 10-15%: Suven Life

    Venkat Jasti, Chairman and CEO, Suven Life Sciences is confident of maintaining EBITDA margins at 32 percent or more. He is also confident of 10-15 percent topline growth in FY17 and FY18.

  • Healthcare Global plans to increase cancer centres to 23 from 19 Nov 11, 2016 12:31 PM IST

    Healthcare Global plans to increase cancer centres to 23 from 19

    Losses arising from new centres have also seen declines in the second quarter of this fiscal.

  • See FY17 topline growth over Rs 1100 cr: Insecticides India Nov 08, 2016 03:12 PM IST

    See FY17 topline growth over Rs 1100 cr: Insecticides India

    Rajesh Aggarwal, Managing Director and CEO, Insecticides is confident of good growth continuing in the second half as well and expects the FY17 topline to be above Rs 1100 crore.

  • Wage hike to impact Q3 margins by 70 bps, Q4 by 10 bps: HCL Tech Oct 21, 2016 12:00 PM IST

    Wage hike to impact Q3 margins by 70 bps, Q4 by 10 bps: HCL Tech

    The IT giant will be the industry leader in organic growth once it acquires the Butler America Aerospace. The acquisition will be completed by December 31 2016.

  • RIL blockbuster numbers to continue into H2; stock to gain: Pros Oct 20, 2016 07:21 PM IST

    RIL blockbuster numbers to continue into H2; stock to gain: Pros

    The company has shown better performance in terms of gross refining margins. Given the higher crude oil prices and their ability to source heavy duty crude at a lower price, the GRM in the third and fourth quarter should remain high, says Deven Choksey, Managing Director at KR Choksey Investment Managers.

  • IPO-bound Endurance focusing on margin, says cash flows strong Oct 05, 2016 11:32 AM IST

    IPO-bound Endurance focusing on margin, says cash flows strong

    The company has a strong cash flow and does not need the money that would come from the IPO, said Anurang Jain, MD, Endurance Technologies.

  • PhillipCap has buy on Britannia with price target Rs 3050 Aug 08, 2016 12:40 PM IST

    PhillipCap has buy on Britannia with price target Rs 3050

    The house currently has a target price of Rs 3050 on the stock and earnings per share estimate Rs 90 for FY18, said Jubil Jain of PhillipCapital.

  • Pending orders may boost revenues 15-20% in FY17: Mangalam Drugs Aug 02, 2016 02:26 PM IST

    Pending orders may boost revenues 15-20% in FY17: Mangalam Drugs

    Govardhan Dhoot, MD, Mangalam Drugs & Organics is confident of improving revenues and growing by 15-20 percent over the last fiscal on back of pending orders.

  • Mining proj in Haryana to boost margins to 15-18%: High Ground Jun 15, 2016 02:40 PM IST

    Mining proj in Haryana to boost margins to 15-18%: High Ground

    High Ground Enterprise's Sandeep Arora hopes for Rs 90-100 crore in revenues from the mining project in FY17.

  • Infosys, HDFC Bank, Aurobindo are top picks: R Sreesankar May 20, 2016 12:37 PM IST

    Infosys, HDFC Bank, Aurobindo are top picks: R Sreesankar

    R Sreesankar, Head Institutional Equities, Prabhudas Lilladher in an interview to CNBC-TV18 shared his rationale for picking Infosys, HDFC Bank, Aurobindo Pharma, Jubilant Life and Glenmark as his top picks.

  • Aiming for double-digit growth in next quarter: Relaxo Footwear May 18, 2016 03:36 PM IST

    Aiming for double-digit growth in next quarter: Relaxo Footwear

    Talking about the outlook for the company going forward, Ramesh Kumar Dua, Managing Director, Relaxo Footwear, said they are aiming for a double-digit growth in the next quarter, with focus on sales transformation and better connection with retailers.

  • Targeting 11% organic revenue growth in FY17: Trigyn Tech May 18, 2016 01:23 PM IST

    Targeting 11% organic revenue growth in FY17: Trigyn Tech

    R Ganapathi, Chairman and Executive Director, Trigyn Technololgies is confident of maintaining strong momentum in managed services vertical.

  • Inox Wind Q4 Net jumps over 77% to Rs 209 crore May 06, 2016 06:54 PM IST

    Inox Wind Q4 Net jumps over 77% to Rs 209 crore

    The consolidated income from operations during the January-March quarter increased to Rs 1,828.65 crore, over Rs 930.05 crore in the year-ago period.

  • No big surprises from Hero; margins may come under pressue:Pros May 05, 2016 07:39 PM IST

    No big surprises from Hero; margins may come under pressue:Pros

    Hero's fourth quarter results met Street estimates. There may not be too much of positive reaction on the stock on Friday but the house has a positive bias on it, says Rahul Korde, Analyst, Prabhudas Lilladher.

  • Long-term debt up due to expansion: Arihant Superstructures May 02, 2016 12:57 PM IST

    Long-term debt up due to expansion: Arihant Superstructures

    Aman Verma, the Chief Financial Officer of Arihant Superstructures says the key to sustainable growth is the identification of right products at right price and for right location that have higher EBITDA margins

  • Hold Cipla; on track to meet 20%+ EBITDA margins in'16: Religare Feb 11, 2016 09:56 AM IST

    Hold Cipla; on track to meet 20%+ EBITDA margins in'16: Religare

    Praful Bohra of Religare is confident of the company clocking EBITDA margins of around 20.7 percent for FY16 and a similar number for FY17 too.

  • Hope to grow revenue by 20-25% in FY17: Just Dial CEO Feb 10, 2016 01:50 PM IST

    Hope to grow revenue by 20-25% in FY17: Just Dial CEO

    Net profit fell 16 percent to Rs 26.99 crore year-on-year (YoY) and EBITDA margins dipped 5.15 percentage points to 26.99 percent (YoY).

  • Increased capacity to come on stream by year-end: Nitin Spinners Feb 10, 2016 09:08 AM IST

    Increased capacity to come on stream by year-end: Nitin Spinners

    For FY17, the company has plans to increase capacities which would come on stream by year-end,said Dinesh Nolkha, Managing Director, Nitin Spinners.

  • Aim to reduce Rs 100 crore debt annually: Meghmani Organics Feb 04, 2016 01:05 PM IST

    Aim to reduce Rs 100 crore debt annually: Meghmani Organics

    The basic chemical business is seeing very good growth because it is directly related to India‘s growth, said Ashish Soparkar, MD, Meghmani Organics, adding that the capacity utilisation for the segment is also at its optimum currently.

  • On track to meet FY16 growth guidance of 10-15%: Monte Carlo Feb 02, 2016 08:55 AM IST

    On track to meet FY16 growth guidance of 10-15%: Monte Carlo

    Sandeep Jain, Executive Director, Monte Carlo Fashion is confident of achieving the FY16 growth target of 10-15 percent.

Sections